1-3 of 3
M. Dimopoulos
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

MMY-3002: A Phase 3 Study Comparing Bortezomib-Melphalan-Prednisone (VMP) with Melphalan-Prednisone (MP) in Newly Diagnosed Multiple Myeloma.

J.F. San Miguel, R. Schlag, N. Khuageva, O. Shpilberg, M. Dimopoulos, M. Kropff, I. Spicka, M. Petrucci, O. Samoilova, A. Dmoszynska, K. Abdulkadyrov, R. Schots, B. Jiang, A. Palumbo, M. Mateos, K. Liu, A. Cakana, H. Van de Velde, P. Richardson
Journal: Blood
Blood (2007) 110 (11): 76.
https://doi.org/10.1182/blood.V110.11.76.76
Published: 2007
Journal Articles

Multiple Myeloma (MM) in Young Patients (pts): Clinical Features and Outcome in 259 Patients Younger Than 40 Years in Comparison to 8,296 pts Aged ≥ 40 Years.

Heinz Ludwig, B. Durie, V. Bolejack, A. Hoering, M. Dimopoulos, R. Kyle, R. Fonseca, M. Beksac, J. San Miguel, J. Crowley, J. Blade, M. Boccadoro, H. Avet Loiseau, G. Morgan, K. Shimizu, C. Shustik, P. Sonneveld, P. Tosi, I. Turesson, J. Westin
Journal: Blood
Blood (2005) 106 (11): 3414.
https://doi.org/10.1182/blood.V106.11.3414.3414
Published: 2005
Journal Articles

Limited value of myeloablative therapy for late multiple myeloma

R Alexanian, M Dimopoulos, T Smith, K Delasalle, B Barlogie, R Champlin
Journal: Blood
Blood (1994) 83 (2): 512–516.
https://doi.org/10.1182/blood.V83.2.512.512
Published: 1994